Clinical Profile, Contemporary Management and One-Year Mortality in Patients with Severe Acute Heart Failure Syndromes: The EFICA Study
Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Catherine Vincent(University of Padua), Patrick Blin(Galen University), Marie‐Hélène Barlet(Institut Icare), Kamran Samii(Université Fédérale de Toulouse Midi-Pyrénées), François Alla(Monsanto (United States)), Yves Juillière(Centre Hospitalier Régional et Universitaire de Nancy), L Paolozzi(Orion Corporation (United Kingdom)), L Guize(Hôpital Européen Georges-Pompidou), Alain Cohen‐Solal(Hôpital Lariboisière), Alexandre Mebazaa(Délégation Paris 5), Michel Desnos(Hôpital Européen Georges-Pompidou), Pierre Rougé(Université Fédérale de Toulouse Midi-Pyrénées)
Cited by 351
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k